TY  - JOUR
AB  - Introduction During the COVID-19 pandemic, stress and anxiety in the population increased due to concerns about people's own health and that of their relatives, as well as changes in everyday life due to measures taken to reduce the infection rate. Pregnant women are particularly stressed. The present study examines how the COVID-19 pandemic affects the stress experience and mental health of pregnant women and mothers of newborns and how care could be optimized. Methods As part of the international COVGEN initiative ( https://www.covgen.org ) to investigate the effects of the COVID-19 pandemic on the peripartum period, pregnant and postpartum women were asked about their experience with stress using the COPE-IS (Coronavirus Perinatal Experiences - Impact Survey) questionnaire developed for this purpose and translated from the English. In addition, demographic data, pre-existing diseases, pregnancy complications and the care situation were recorded. The questionnaire was either administered as hardcopy to inpatients at the Department of Women's Health, University Hospital Tübingen, Germany, or online. All pregnant women and mothers who were pregnant or had given birth after the official start of the COVID-19 pandemic (11 March 2020) were eligible to participate. Results Complete data sets of n = 156 pregnant women and n = 221 postpartum women were available for evaluation. The general stress level assessed with the COPE-IS was significantly increased by the COVID-19 pandemic in both, pregnant and postpartum women, with pre-existing conditions such as respiratory diseases and pregnancy-related diseases like gestational diabetes adding to the stress. The subjectively perceived quality of care/support during pregnancy also influenced the stress level. Conclusions Fears of a COVID-19 infection and changes in preventive and aftercare services were a burden for the women surveyed. Intensified care during pregnancy and puerperium could help to stabilize the mental situation and reduce stress.
AU  - Kentschke, D.
AU  - Bauer, I.
AU  - Moser, J.
AU  - Schleger, F.
AU  - Hahn, M.*
AU  - Pauluschke-Fröhlich, J.*
AU  - Jakubowski, P.*
AU  - Abele, H.*
AU  - Preissl, H.
AU  - Hartkopf, J.
C1  - 66602
C2  - 53237
SP  - 1265-1273
TI  - COVID-19 and perinatal stress experience - a study conducted as part of the COVGEN initiative.
JO  - Geburtsh. u. Frauenheilk.
VL  - 82
IS  - 11
PY  - 2022
SN  - 0016-5751
ER  - 

TY  - JOUR
AB  - Introduction The mammography screening programme has been the subject of criticism for some time. Invitation to take part is currently based only on the risk factors of age and female sex, whereby women with an above-average risk are screened too seldom and women with a low risk are possibly screened too often. In future, an individualised risk assessment could make a risk-adapted procedure possible in breast cancer screening. In the RISIKOLOTSE.DE project, schemes are devised to calculate the individual breast cancer risk and evaluate the results. The aim is to assist doctors and screening participants in participatory decision-making. To gauge the baseline situation in the target groups, qualitative and quantitative surveys were conducted. Method At the start of the project, a guideline-based focus group discussion was held with 15 doctors and representatives of the public health service. The transcript of this discussion was evaluated by means of a qualitative content analysis. Results The participants assessed the concept of risk-adapted screening positively overall. At the same time, the majority of them were of the opinion that the results of individualised risk calculation can be understood and evaluated adequately only by doctors. The great communication requirement and lack of remuneration were given as practical obstacles to implementation. Discussion The suggestions and new ideas from the focus group ranged from administrative and regulatory changes to new forms of counselling and adaptable practice aids. An important indicator for the RISIKOLOTSE.DE conception and for planning future surveys was that risk calculation for mammography screening 2.0 was regarded as a purely medical function and that the concept of participatory decision-making played hardly any part in the discussion.
AU  - Fuerst, N.*
AU  - Kiechle, M.*
AU  - Strahwald, B.*
AU  - Quante, A.S.
C1  - 54068
C2  - 45291
CY  - Rudigerstr 14, D-70469 Stuttgart, Germany
SP  - 506-511
TI  - Mammography screening 20 - How can risk-adapted screening be implemented in clinical practice? Results of a focus group discussion with experts in the RISIKOLOTSE.DE project.
JO  - Geburtsh. u. Frauenheilk.
VL  - 78
IS  - 5
PB  - Georg Thieme Verlag Kg
PY  - 2018
SN  - 0016-5751
ER  - 

TY  - JOUR
AB  - A team of experts from the fields of gynaecology and obstetrics, diabetology, internal medicine, paediatrics and midwifery from Germany, Austria and Switzerland produced a new version of the existing S3 guideline on gestational diabetes. It replaces the recommendations of the German Association for Gynaecology and Obstetrics and the German Diabetes Association on the diagnosis and treatment of gestational diabetes from 2011 and is valid for the three German-speaking countries. The primary aim of the guideline is to improve and standardise the prevention, screening, diagnosis, treatment and follow-up of gestational diabetes through evidence-based recommendations for the outpatient and inpatient area. A large number of new studies and data published in the last few years required a comprehensive revision of the 2011 guideline. The new aspects include early screening of pregnant women with a high risk for diabetes or gestational diabetes, the validity of two-stage screening in the third trimester by means of the 50-g challenge test, as specified in the maternity guidelines, use of metformin instead of or in addition to insulin in gestational diabetes, and birth planning with GDM and/or macrosomia. The recommendations are based on the evidence from the literature, which was selected through a systematic external literature search. All recommendations had to pass through a consensus process. The present text corresponds to the practice guideline on gestational diabetes, which is an action-oriented short version of the evidence-based S3 guideline that can be viewed on the internet.
AU  - Schäfer-Graf, U.M.*
AU  - Gembruch, U.*
AU  - Kainer, F.*
AU  - Groten, T.*
AU  - Hummel, S.
AU  - Hösli, I.*
AU  - Grieshop, M.*
AU  - Kaltheuner, M.*
AU  - Bührer, C.*
AU  - Kautzky-Willer, A.*
AU  - Laubner, K.*
AU  - Bancher-Todesca, D.*
C1  - 55068
C2  - 46054
CY  - Rudigerstr 14, D-70469 Stuttgart, Germany
SP  - 1219-1231
TI  - Gestational Diabetes Mellitus (GDM) - Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018).
JO  - Geburtsh. u. Frauenheilk.
VL  - 78
IS  - 12
PB  - Georg Thieme Verlag Kg
PY  - 2018
SN  - 0016-5751
ER  - 

TY  - JOUR
AU  - Ulrich, M.
AU  - Winkler, C.
AU  - Ziegler, A.-G.
C1  - 52578
C2  - 44057
CY  - Stuttgart
SP  - 1151-1153
TI  - New study on the prevention of type-1-diabetes.
JO  - Geburtsh. u. Frauenheilk.
VL  - 77
IS  - 11
PB  - Georg Thieme Verlag Kg
PY  - 2017
SN  - 0016-5751
ER  - 

TY  - JOUR
AB  - Es wird über die Ergebnisse zytologischer Krebsfrüherkennungs- und Vorsorgeuntersuchungen bei der Frau berichtet. Die über einen 10-Jahres-Zeitraum gehende Studie umfaßt 748871 Untersuchungen bei 281705 Frauen. Darunter befinden sich zahlreiche Langzeitbeobachtungen. Von 28171 Frauen (10%) liegen jeweils mehr als fünf Wiederholungsuntersuchungen aus dem genannten Zeitraum vor. Für die Effektivität der Screeninguntersuchungen sprechen aufgrund der vorgelegten Befunde: Der Abfall der zytologischen Entdeckungsraten zwischen Erst- und Wiederholungsuntersuchungen, der erneute Anstieg der Entdeckungsraten bei längeren Untersuchungsintervallen, die Verschiebung der Relation von Dysplasien, Carcinomata in situ und invasiven Zervixkarzinomen zugunsten der leichteren Erkrankungen. Die Neuentdockungsrate der Zervixkamnome sank in den Jahren 1971 bis 1980 von 0,9 ‰ auf 0,2 ‰, die der Carcinomata in situ und der schweren Dysplasien von 3,5 ‰ auf 1.2 ‰ ab. Für die zukünftige Planung von Screeningprogrammen sind verschiedene Probleme zu berücksichtigen, wie die geringe Beteiligung der Frauen an regelmäßigen Krebsvorsorgeuntersuchungen, die hohe Rate falschnegativer zytologischer Befunde und Fragen der Effizienz der Programme in mehrfach durchuntersuchten Bevölkerungsgruppen.
AU  - Soost, H.-J.
AU  - Lehmacher, W.
AU  - Ruffing-Kullmann, B.
C1  - 17901
C2  - 10945
SP  - 579-586
TI  - Wieweit haben die Krebsfrüherkennungs- und Vorsorgeuntersuchungen für das Karzinom der Cervix uteri die an sie gestellten Erwartungen erfüllt?.
JO  - Geburtsh. u. Frauenheilk.
VL  - 49
IS  - 6
PY  - 1989
SN  - 0016-5751
ER  -